Acrylamide was polymerized in aqueous solution with chlorate‐sulfite initiator under the following conditions: temperature, 15–75°C.; pH, 1.5–3.9; monomer concentration, 0.3–1.1 mole/liter; NaClO3 concentration, 0.26–2.1 × 10−4 mole/liter; and Na2‐SO3 concentration, 0.79–6.3 × 10−4 mole/liter. The weight‐average molecular weight of the polymers formed under these conditions is in the range of 1–3 × 106. It was found that up to 40–50% conversion, the following rate equation holds: where Rp is the overall rate of polymerization, [M] the instantaneous monomer concentration at time t, and [M]0 the initial monomer concentration. At 50°C., K = 6.9 ± 0.9 l. mole−1 sec.−1 Activation energy within the temperature range studied was found to be 7.3 kcal./mole. The value of k 2italicp/kt at 50°C. was estimated to be about 30 l. mole−1 sec.−1 The rate dependence on [M]5/2[M]−3/20 is explained by assuming that the polymer formed binds part of the remaining monomer. The presence of ferrous ions in the polymerization system increases the rate but decreases the molecular weight of the polymer formed. Up to 3.6 × 10−3 mole/l. of [Fe++], the rate is affected in such a manner that Chromic ions tend to retard and nickel ions tend to accelerate the rate of polymerization. It was found that HSO3− is an effective chain transfer agent. Its chain transfer constant was estimated to be about 0.17.
BackgroundProjection analyses can provide estimates of the future health burden of increasing BMI and represent a relevant and useful tool for public health planning. Our study presents long-term (2013–2030) projections of the prevalence and numbers of individuals by BMI category for adult men and women in Quebec. Three applications of projections to estimate outcomes more directly pertinent to public health planning, as well as an in-depth discussion of limits, are provided with the aim of encouraging greater use of projection analyses by public health officers.MethodsThe weighted compositional regression method is applied to prevalence time series derived from sixteen cross-sectional survey cycles, for scenarios of linear change and deceleration. Estimation of the component of projected change potentially amenable to intervention, future health targets and the projected impact on type 2 diabetes, were done.ResultsObesity prevalence in Quebec is projected to rise steadily from 2013 to 2030 in both men (from 18.0-19.4% to 22.2-30.4%) and women (from 15.5-16.3% to 18.2-22.4%). Corresponding projected numbers of obese individuals are (579,000-625,000 to 790,000-1,084,000) in men and (514,000-543,000 to 661,000-816,000) in women. These projected increases are found to be primarily an ‘epidemiologic’ rather than ‘demographic’ phenomenon and thus potentially amenable to public health intervention. Assessment of obesity targets for 2020 illustrates the necessity of using projected rather than current prevalence; for example a targeted 2% drop in obesity prevalence relative to 2013 translates into a 3.6-5.4% drop relative to 2020 projected levels. Type 2 diabetes is projected to increase from 6.9% to 9.2-10.1% in men and from 5.7% to 7.1-7.5% in women, from 2011–2012 to 2030. A substantial proportion of this change (25-44% for men, and 27-43% for women) is attributable to the changing BMI distribution.ConclusionsObesity in Quebec is projected to increase and should therefore continue to be a public health priority. Application of projections to estimate the proportion of change potentially amenable to intervention, feasible health targets, and future chronic disease prevalence are demonstrated. Projection analyses have limitations, but represent a pertinent tool for public health planning.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2458-14-996) contains supplementary material, which is available to authorized users.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.